Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Cardiology

What Is the Treatment for Refractory Prinzmetal Angina?

At a Glance

For refractory Prinzmetal angina, cardiologists usually maximize a safe calcium channel blocker dose or combine two types, then consider add-on medicines such as long-acting nitrates or nicorandil. Persistent or changing chest pain needs urgent evaluation.

When daily medication isn’t enough to prevent the chest pain of Prinzmetal (vasospastic) angina, it can be incredibly frustrating. Refractory vasospastic angina means that you are still experiencing persistent, recurrent coronary spasms despite taking your calcium channel blockers exactly as prescribed [1].

If your symptoms are not well controlled, there are several next-step strategies. The most common approach is to optimize your current medication dose, safely combine it with a second daily medication, or explore specialized therapies.

Important: Prevention vs. Emergency Action
It is critical to understand the difference between preventative daily medications (like your daily calcium channel blockers) and acute relief medications used during an attack [2]. Daily medications reduce the frequency and severity of future episodes, but they do not stop an attack that is already happening.

  • During an attack: Use your prescribed short-acting nitrate (like nitroglycerin under the tongue) exactly as directed by your doctor.
  • When to seek emergency care: Coronary spasms can cause dangerous heart rhythms or a heart attack [3]. Call emergency services (do not drive yourself) if your pain does not improve after using your short-acting nitrate, if it feels different or more severe than usual, or if it is accompanied by shortness of breath, fainting, heavy sweating, or palpitations.

Optimizing Your First-Line Therapy

Before moving to completely new medications, your cardiologist will likely evaluate how you are taking your current calcium channel blockers (CCBs). High-dose CCB therapy has the strongest evidence for reducing the frequency and duration of vasospastic episodes [4][2].

  • Increasing the dose: Your doctor may increase your CCB to the maximum dose your body can safely tolerate [4].
  • Combining CCBs: There are different classes of CCBs. Doctors may combine a “dihydropyridine” CCB (like amlodipine) with a “non-dihydropyridine” CCB (like diltiazem or verapamil) because they relax the blood vessels in slightly different, complementary ways [5][6].

Safety Note: Never adjust, double, or stop your CCB doses on your own. These medications require medical monitoring for side effects like ankle swelling, low blood pressure, a dangerously slow heart rate, or electrical conduction issues in the heart [5].

Add-On Medications

If maximizing CCBs isn’t enough, your care team may add other medications.

Long-Acting Nitrates

While short-acting nitrates stop an active attack, long-acting nitrates can be taken daily as an add-on preventative measure to keep blood vessels relaxed [2][4]. Your doctor will monitor you closely, as the evidence supporting long-acting nitrates is less robust than for CCBs [4][5].

Safety Note: Long-acting nitrates require a specific dosing schedule—often including a “nitrate-free” window each day—to prevent your body from building a tolerance to the drug [2][7]. Never combine nitrates with phosphodiesterase-5 (PDE-5) inhibitors used for erectile dysfunction (such as sildenafil or tadalafil) or riociguat, as this combination can cause a fatal drop in blood pressure.

Nicorandil

In countries where it is approved and available, nicorandil is often used as a specialist second-line add-on when CCBs aren’t fully effective [2][4]. It is not routinely available in all health systems. It has both potassium-channel-opening and nitrate-like activity, but carries risks of severe headaches, low blood pressure, and rare but serious gastrointestinal or mucosal ulcers.

Statins and Cardiovascular Risk

While statins are well known for lowering cholesterol, some observational research associates statin use with fewer major cardiac events in people with vasospastic angina [8]. However, statins do not directly treat or prevent the physical spasms themselves [4]. They are typically prescribed if you have high cholesterol, underlying atherosclerotic blockages, or other cardiovascular risk factors.

Specialized and Investigational Options

For highly refractory cases, an experienced specialist may explore less common or off-label therapies:

  • Fasudil: A Rho-kinase inhibitor that blocks a specific cellular pathway involved in blood vessel constriction [9]. It is largely considered an investigational or region-specific specialist option and is not a routine outpatient treatment [2].
  • Cilostazol and Alpha-1 Blockers: Small studies suggest these might help some patients, but the evidence is limited [10][4]. These are off-label approaches with important risks: cilostazol has strict cardiovascular contraindications and can cause rapid heart rate (tachycardia) or bleeding, while alpha-1 blockers can cause severe drops in blood pressure when standing [4].

Reviewing Triggers and Other Medications

If you are still experiencing spasms, it is crucial to review anything that might be provoking them.

  • Stimulants and Decongestants: Over-the-counter cold medicines containing decongestants (like pseudoephedrine or phenylephrine), as well as cocaine or amphetamines, are stimulants that can directly trigger coronary spasms [11][12]. Check every new medication with your pharmacist.
  • Beta-blockers: Nonselective beta-blockers can actually aggravate coronary spasms in some people [4][13]. However, never stop a beta-blocker abruptly on your own. Abruptly stopping can be dangerous. If you are prescribed a beta-blocker for another necessary condition, your doctor will carefully manage and balance your treatments.
  • Lifestyle Factors: Smoking is a powerful trigger for spasms; ask your care team for practical cessation support [11]. While emotional stress or sudden physical exertion can be triggers [12][14], you should not unnecessarily avoid all activity. Ask your doctor or cardiac rehabilitation team for safe exercise guidance.

Rethinking the Diagnosis

If your chest pain persists or changes despite aggressive treatment, it requires urgent medical assessment. Your doctor may want to investigate further to ensure the pain is strictly from epicardial spasm (spasms in the large surface arteries of the heart).

Specialized centers may use provocative testing or advanced imaging during a cardiac catheterization to check if your chest pain is being caused by microvascular spasm (dysfunction in the tiny vessels deep inside the heart muscle) or an underlying physical plaque blockage that wasn’t previously seen [15][5].

Common questions in this guide

What is the first medication step when Prinzmetal angina remains uncontrolled?
Doctors usually first check that the medicine is being taken as prescribed and increase a calcium channel blocker to the highest safe dose. If one type is not enough, they may combine two different calcium channel blockers, with monitoring for low blood pressure, a slow heart rate, ankle swelling, or heart conduction problems. Do not change or stop either medicine without medical guidance.
Can long-acting nitrates or nicorandil help refractory Prinzmetal angina?
They may be added when calcium channel blockers do not fully control symptoms. Long-acting nitrates often require a daily nitrate-free interval, while nicorandil is available only in some countries. Nitrate medicines must not be combined with sildenafil, tadalafil, or riociguat because blood pressure can fall dangerously.
What should I do if nitroglycerin does not relieve a Prinzmetal angina attack?
Use your prescribed short-acting nitrate exactly as directed, and call emergency services if the pain does not improve. Also seek emergency help if the pain is different or more severe than usual or occurs with shortness of breath, fainting, heavy sweating, or palpitations. Do not drive yourself.
Could another medicine or lifestyle factor be worsening my coronary spasms?
Yes. Decongestants, cocaine, amphetamines, smoking, emotional stress, cold exposure, sudden exertion, and some nonselective beta-blockers can worsen spasms in some people. Do not stop a beta-blocker abruptly; ask your doctor or pharmacist to review all prescription, over-the-counter, and supplement use.
What tests may be needed if symptoms continue despite treatment?
A specialized center may use provocative testing or advanced imaging during cardiac catheterization to determine whether symptoms come from spasms in the large surface coronary arteries, spasms in the heart’s tiny vessels, or a fixed plaque blockage. Persistent or changing chest pain requires prompt medical assessment.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Prinzmetal angina.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is my current daily calcium channel blocker at the maximum safe dose, and should we consider safely combining two different CCB classes?
  2. 2.Would adding a long-acting nitrate or nicorandil be an appropriate next step, and how do we schedule it to prevent medication tolerance?
  3. 3.Are there any medications I am currently taking—such as beta-blockers, over-the-counter decongestants, or supplements—that could be worsening my spasms?
  4. 4.What is my personalized emergency action plan if my short-acting nitrate does not stop an attack?
  5. 5.Do my ongoing symptoms suggest we need to investigate for microvascular dysfunction or fixed blockages at a specialized center?

References

References (15)
  1. 1

    Severe familial coronary artery spasm in 2 siblings: About 2 cases.

    Kerrouani O, Faraj R, Bouchaala A, et al.

    Radiology case reports 2023; (18(12)):4374-4379 doi:10.1016/j.radcr.2023.09.005.

    PMID: 37840889
  2. 2

    Management of Coronary Artery Spasm.

    Lanza GA, Shimokawa H

    European cardiology 2023; (18()):e38 doi:10.15420/ecr.2022.47.

    PMID: 37456765
  3. 3

    Variant Angina and Aborted Sudden Cardiac Death.

    Kundu A, Vaze A, Sardar P, et al.

    Current cardiology reports 2018; (20(4)):26 doi:10.1007/s11886-018-0963-1.

    PMID: 29520510
  4. 4

    Pharmacotherapy of Vasospastic Angina.

    Harris JR, Hale GM, Dasari TW, Schwier NC

    Journal of cardiovascular pharmacology and therapeutics 2016; (21(5)):439-51 doi:10.1177/1074248416640161.

    PMID: 27081186
  5. 5

    Invasive Evaluation for Coronary Vasospasm.

    Huang J, Steinberg R, Brown MJ, et al.

    US cardiology 2023; (17()):e07 doi:10.15420/usc.2022.33.

    PMID: 39493950
  6. 6

    Coronary Artery Spasm: New Insights.

    Matta A, Bouisset F, Lhermusier T, et al.

    Journal of interventional cardiology 2020; (2020()):5894586 doi:10.1155/2020/5894586.

    PMID: 32508542
  7. 7

    Drug challenge test for early symptom control in patients with coronary artery spasm: a case report.

    Kawase Y, Kikuchi K, Mizukami T, Matsuo H

    European heart journal. Case reports 2025; (9(4)):ytaf134 doi:10.1093/ehjcr/ytaf134.

    PMID: 40201403
  8. 8

    Impact of Statin Therapy on Clinical Outcome in Patients With Coronary Spasm.

    Ishii M, Kaikita K, Sato K, et al.

    Journal of the American Heart Association 2016; (5(5)).

    PMID: 27207970
  9. 9

    Coronary Functional Abnormalities in Patients With Angina and Nonobstructive Coronary Artery Disease.

    Suda A, Takahashi J, Hao K, et al.

    Journal of the American College of Cardiology 2019; (74(19)):2350-2360 doi:10.1016/j.jacc.2019.08.1056.

    PMID: 31699275
  10. 10

    The Impact of Cilostazol in Refractory Vasospastic Angina.

    Lin RZ, Tavella R, Shakib S, Beltrame JF

    Cardiology 2026; (151(2)):162-167 doi:10.1159/000544943.

    PMID: 40015253
  11. 11

    The Smoking Paradox: A Twist in the Tale of Vasospastic Angina.

    Tran MV, Marceau E, Lee PY, et al.

    Journal of vascular medicine & surgery 2021; (9(7)).

    PMID: 36276915
  12. 12

    Tacrolimus-Induced Diffuse Coronary Artery Spasm.

    Samer A, Almehmadi F, Krimly A, Alrajhi A

    Cureus 2022; (14(6)):e25748 doi:10.7759/cureus.25748.

    PMID: 35812568
  13. 13

    Long-term prognosis of patients with life-threatening ventricular arrhythmias induced by coronary artery spasm.

    Rodríguez-Mañero M, Oloriz T, le Polain de Waroux JB, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2018; (20(5)):851-858 doi:10.1093/europace/eux052.

    PMID: 28387796
  14. 14

    Vasospastic angina: a review on diagnostic approach and management.

    Jenkins K, Pompei G, Ganzorig N, et al.

    Therapeutic advances in cardiovascular disease 2024; (18()):17539447241230400 doi:10.1177/17539447241230400.

    PMID: 38343041
  15. 15

    Vasospastic angina: A literature review of current evidence.

    Picard F, Sayah N, Spagnoli V, et al.

    Archives of cardiovascular diseases 2019; (112(1)):44-55 doi:10.1016/j.acvd.2018.08.002.

    PMID: 30197243

This page explains treatment options for refractory Prinzmetal angina for informational purposes only and does not constitute medical advice. Do not change heart medicines yourself, and seek emergency care for chest pain that does not improve with prescribed nitroglycerin.